Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.
Biocorrosion properties and blood- and cell compatibility of pure iron were studied in comparison with 316L stainless steel and Mg-Mn-Zn magnesium alloy to reveal the possibility of pure iron as a biodegradable biomaterial. Both electrochemical and weight loss tests showed that pure iron showed a relatively high corrosion rate at the first several days and then decreased to a low level during the following immersion due to the formation of phosphates on the surface. However, the corrosion of pure iron did not cause significant increase in pH value to the solution. In comparison with 316L and Mg-Mn-Zn alloy, the pure iron exhibited biodegradable property in a moderate corrosion rate. Pure iron possessed similar dynamic blood clotting time, prothrombin time and plasma recalcification time to 316L and Mg-Mn-Zn alloy, but a lower hemolysis ratio and a significant lower number density of adhered platelets. MTT results revealed that the extract except the one with 25% 24 h extract actually displayed toxicity to cells and the toxicity increased with the increasing of the iron ion concentration and the incubation time. It was thought there should be an iron ion concentration threshold in the effect of iron ion on the cell toxicity.
Zhang
Erlin
E
Institute of Metal Research, Chinese Academy of Sciences, Shenyang 110016, China. zhangerlin2009@163.com
Chen
Haiyan
H
Shen
Feng
F
D000497:Alloys / Q000737:chemistry; D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D003343:Corrosion; D004563:Electrochemistry; D004912:Erythrocytes / Q000737:chemistry*; D006461:Hemolysis / Q000502:physiology; D007501:Iron / Q000097:blood* / Q000737:chemistry*; D008274:Magnesium / Q000737:chemistry; D010710:Phosphates / Q000737:chemistry; D011817:Rabbits; D013193:Stainless Steel / Q000737:chemistry
D000497:Alloys; D001672:Biocompatible Materials; D010710:Phosphates; D013193:Stainless Steel; D007501:Iron; D008274:Magnesium
Science. 1987 Sep 25;237(4822):1588-95
3629258
Nutrition. 2001 Jul-Aug;17(7-8):679-80
11448600
Mol Aspects Med. 2005 Aug-Oct;26(4-5):313-27
16112186
Int J Pharm. 2007 Feb 7;330(1-2):45-53
17008035
Science. 2002 Feb 8;295(5557):1014-7
11834817
J Interv Cardiol. 2008 Feb;21(1):15-20
18086136
Biomaterials. 2009 Apr;30(10):1857-69
19168215
Hemoglobin. 2008;32(1-2):17-28
18274979
FASEB J. 1997 Sep;11(11):851-7
9285483
Mol Aspects Med. 2001 Feb-Apr;22(1-2):1-87
11207374
Acta Biomater. 2009 Jul;5(6):2206-12
19264564
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G417-22
16474007
Heart. 2001 Nov;86(5):563-9
11602554
J Mater Sci Mater Med. 2008 Mar;19(3):1017-25
17665099
J Mater Sci Mater Med. 2009 Apr;20(4):859-67
19034618
Clin Exp Immunol. 2004 Jul;137(1):109-16
15196250
Am J Med Sci. 1999 Oct;318(4):207-12
10522549
J Inorg Biochem. 2002 Jul 25;91(1):9-18
12121757
Biomaterials. 2006 Oct;27(28):4955-62
16765434
Int J Pharm. 2001 Jun 19;221(1-2):1-22
11397563
Biomaterials. 2009 Feb;30(4):484-98
19000636
Cancer Res. 2006 Mar 1;66(5):2749-56
16510596
Acta Biomater. 2007 Jul;3(4):541-9
17383247
Am J Hematol. 2007 Dec;82(12 Suppl):1128-31
17963252
Endocrinology. 2007 Jul;148(7):3053-5
17575059
Acta Biomater. 2007 Jul;3(4):597-605
17291842
Clin Chim Acta. 2005 Aug;358(1-2):24-36
15885682
Clin Chem. 2000 Aug;46(8 Pt 2):1260-9
10926920
Biochim Biophys Acta. 2006 Jul;1763(7):652-67
16843540
Bull Acad Natl Med. 2005 Nov;189(8):1635-47; discussion 1647
16737091
Biomaterials. 2006 Mar;27(9):1728-34
16246414
Science. 1980 May 23;208(4446):826-31
6246576
Biomaterials. 2002 Feb;23(4):1139-45
11791917
Int J Hematol. 2002 Oct;76(3):219-28
12416732
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G798-804
19179627
Science. 1984 Nov 9;226(4675):630-6
6093253
Am J Physiol Renal Physiol. 2003 Jul;285(1):F9-18
12788784
Food Nutr Bull. 2007 Dec;28(4 Suppl):S500-9
18297888
Free Radic Biol Med. 2002 May 1;32(9):833-40
11978485